182 related articles for article (PubMed ID: 36152114)
1. The combination of BRAF
Li Q; Yang L; Lv J; Xu L; Zhang M; Li S
Endocrine; 2022 Dec; 78(3):507-516. PubMed ID: 36152114
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic Value of American Thyroid Association Guidelines,American College of Radiology Thyroid Imaging Reporting and Data System,and Chinese Thyroid Imaging Reporting and Data System Alone and Combined With BRAF
Lin Y; Luo YK; Li J; Ren XY; Wang HW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Dec; 45(6):921-928. PubMed ID: 38173102
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
[TBL] [Abstract][Full Text] [Related]
4. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
Jeong SH; Hong HS; Lee EH; Cha JG; Park JS; Kwak JJ
AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
Hong HS; Lee JY
AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
[No Abstract] [Full Text] [Related]
6. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
[TBL] [Abstract][Full Text] [Related]
7. An economically efficient strategy for diagnosing atypia of undetermined significance or follicular lesion of undetermined significance thyroid nodules with ultrasound-based risk stratification systems and
Ma X; Huang Y; Shen R; Cui Y; Kang Y; Yu J; Cui K
Quant Imaging Med Surg; 2024 Jan; 14(1):920-931. PubMed ID: 38223096
[TBL] [Abstract][Full Text] [Related]
8. Utility of Six Ultrasound-Based Risk Stratification Systems in the Diagnosis of AUS/FLUS Thyroid Nodules.
Li Q; Yang L; Yang L; Jiang X; Li S
Acad Radiol; 2024 Jan; 31(1):131-141. PubMed ID: 37225530
[TBL] [Abstract][Full Text] [Related]
9. Strategy to reduce unnecessary surgeries in thyroid nodules with cytology of Bethesda category III (AUS/FLUS): a retrospective analysis of 667 patients diagnosed by surgery.
Suh YJ; Choi YJ
Endocrine; 2020 Sep; 69(3):578-586. PubMed ID: 32297204
[TBL] [Abstract][Full Text] [Related]
10. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
Hyeon J; Ahn S; Shin JH; Oh YL
Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
[TBL] [Abstract][Full Text] [Related]
11. Clinical Parameter for Deciding the BRAFV600E Mutation Test in Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Thyroid Nodules: US Features According to TIRADS.
Rho M; Kim EK; Moon HJ; Yoon JH; Park VY; Han K; Kwak JY
Ultrasound Q; 2017 Dec; 33(4):284-288. PubMed ID: 28877096
[TBL] [Abstract][Full Text] [Related]
12. Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.
Park VY; Kim EK; Kwak JY; Yoon JH; Moon HJ
Eur Radiol; 2015 Sep; 25(9):2601-7. PubMed ID: 25740802
[TBL] [Abstract][Full Text] [Related]
13. Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations.
Bellevicine C; Sgariglia R; Migliatico I; Vigliar E; D'Anna M; Nacchio MA; Serra N; Malapelle U; Bongiovanni M; Troncone G
Cancer Cytopathol; 2018 May; 126(5):317-325. PubMed ID: 29469940
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of Thyroid Imaging Reporting and Data System in the prediction of malignancy in nodules with atypia and follicular lesion of undetermined significance cytologies.
Baser H; Cakir B; Topaloglu O; Alkan A; Polat SB; Dogan HT; Yazicioğlu MO; Aydin C; Ersoy R
Clin Endocrinol (Oxf); 2017 Apr; 86(4):584-590. PubMed ID: 27911001
[TBL] [Abstract][Full Text] [Related]
15. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
Zhang YZ; Xu T; Cui D; Li X; Yao Q; Gong HY; Liu XY; Chen HH; Jiang L; Ye XH; Zhang ZH; Shen MP; Duan Y; Yang T; Wu XH
Sci Rep; 2015 Nov; 5():16927. PubMed ID: 26597052
[TBL] [Abstract][Full Text] [Related]
16. Risk Stratification of Thyroid Nodules With Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance (AUS/FLUS) Cytology Using Ultrasonography Patterns Defined by the 2015 ATA Guidelines.
Lee JH; Han K; Kim EK; Moon HJ; Yoon JH; Park VY; Kwak JY
Ann Otol Rhinol Laryngol; 2017 Sep; 126(9):625-633. PubMed ID: 28719972
[TBL] [Abstract][Full Text] [Related]
17. Improving the diagnosis of AUS/FLUS thyroid nodules using an algorithm with combination of BRAFV600E mutation analysis and ultrasound pattern-based risk stratification.
Zhou YF; Zhang YF; Fu HJ; Yang WP; Zhao CK; Xu HX
Clin Hemorheol Microcirc; 2021; 77(3):273-285. PubMed ID: 33185592
[TBL] [Abstract][Full Text] [Related]
18. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
[TBL] [Abstract][Full Text] [Related]
19. Thyroid nodules with atypia or follicular lesions of undetermined significance (Bethesda Category III): importance of ultrasonography and cytological subcategory.
Rosario PW
Thyroid; 2014 Jul; 24(7):1115-20. PubMed ID: 24684285
[TBL] [Abstract][Full Text] [Related]
20. Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
Kim J; Shin JH; Oh YL; Hahn SY; Park KW
Endocr J; 2022 Jan; 69(1):67-74. PubMed ID: 34408101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]